Harmony Biosciences Holdings (HRMY) Current Assets (2019 - 2026)

Harmony Biosciences Holdings' Current Assets history runs 8 years deep, the most recent figure standing at $778.8 million for Q1 2026.

• In Q1 2026, Current Assets rose 21.18% year-over-year to $778.8 million; the TTM figure through Mar 2026 stood at $778.8 million (up 21.18% YoY), while the FY2025 annual figure was $907.0 million, up 56.58% from the prior year.
• Current Assets came in at $778.8 million for Q1 2026 at Harmony Biosciences Holdings, down from $907.0 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $907.0 million in Q4 2025 to a low of $280.3 million in Q1 2022.
• A 5-year average of $533.6 million and a median of $463.0 million in 2023 frame the typical range for Current Assets.
• Across the five-year window, Current Assets gained 0.59% in 2024 and surged 60.57% in 2025, its largest moves.
• Harmony Biosciences Holdings' Current Assets stood at $400.3 million in 2022, then gained by 12.69% to $451.1 million in 2023, then advanced by 28.42% to $579.3 million in 2024, then soared by 56.58% to $907.0 million in 2025, then dropped by 14.13% to $778.8 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $778.8 million, $907.0 million, and $838.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison